Long Covid Symptoms

Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC, and Anuj Aggrawal, MD, discuss diagnosing background pain following a SARS-CoV-2 acute infection, at the 2024 Pain Week ...

Pediatric Research - Post-COVID-19 condition in children: epidemiological evidence stratified by acute disease severity

People with symptoms of COVID-19 that persist weeks or months after they get infected are known as long-haulers. Stacker put together a list of the symptoms most often reported by them.

'Whenever I'd brush my hair in the shower, I'd have proper clumps come out'

New research highlights a complex relationship between COVID-19 and cognitive function, suggesting that even mild infections can lead to subtle memory and attention deficits lasting at least a year.

The following is a summary of “Long COVID is not the same for everyone: a hierarchical cluster analysis of Long COVID symptoms 9 and 12 months after SARS-CoV-2 test,” published in the September 2024 issue of Infectious Diseases by Moniz et al. Determining symptom clusters in long COVID is essential for creating targeted treatments and

While long COVID symptoms have been seen to have lasting impacts, a new Irish study by the Mater Private Network shows minimal long-term heart damage for patients

Research conducted as part of the COVID-CNS Consortium shows that 12-18 months after hospitalization due to COVID-19, patients have worse cognitive function than matched control participants.

COVID-19 patients show substantial cognitive decline 12-18 months after hospitalization , But they may be able to recover, a new study shows.

Researchers found that people with long COVID were more likely to have symptoms such as dizziness or palpitations when standing up.

Individuals with long Covid should avoid foods like sushi, burgers, and salads due to their potential risks. Raw fish in sushi can lead to foodborne illnesses, while burgers high in saturated fats may exacerbate inflammation and fatigue. Even salads can pose risks if not carefully prepared, as raw vegetables might harbor harmful bacteria, and certain dressings can increase inflammation. Instead, it's recommended to focus on easily digestible, nutrient-dense foods that support immune function and reduce inflammation, aiding recovery. Adding ingredients like onions, peppers, and lime can enhance nutrition without compromising safety.

Long Covid: in children it can last up to three years, the results of an international study Read the news on Agenzia Nova

Researchers from the UK conducted the first human challenge study of SARS-CoV-2, revealing long-lasting cognitive deficits in unvaccinated participants infected with the virus, especially in memory and executive function.

Multiple sclerosis (MS) research has uncovered a potential link between certain initial symptoms and long-term disability outcomes. The study, "The association of different acute manifestations of multiple ...

Millions have been infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) since its emergence in 2019, but most patients make a full reco...

A recent study found that fatigue in Long COVID is linked to distinct patterns of brain connectivity, particularly in the frontal and cerebellar regions, with mental and physical fatigue showing different connectivity patterns, suggesting unique neural mechanisms for each.

A professor at Eastern Michigan University compiled stories of women in journalism who covered COVID, collecting oral histories of how the pandemic affected their work and lives.  GUEST: • You Li, Assoc Professor of Journalism, EMU See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information.

A recent study from Kennedy Krieger Institute shows that the majority of children diagnosed with long COVID are likely to experience orthostatic intolerance (OI), a condition that causes the body to struggle with regulating blood pressure and heart rate when standing up. As a result, children often feel dizzy, lightheaded, fatigued and may experience "brain fog" or cognitive difficulties.

The recognition of post-viral syndrome-related cognitive changes helps reduce stigma, improve clinical management, and empower patients to seek support

The latest COVID vaccine is available now.

Background Identifying symptom clusters in Long COVID is necessary for developing effective therapies for this diverse condition and improving the quality of life of those affected by this heterogeneous condition. In this study, we aimed to identify and compare symptom clusters at 9 and 12 months after a SARS-CoV-2 positive test and describe each cluster regarding factors at infection. Methods This is a cross-sectional study with individuals randomly selected from the Portuguese National System of Epidemiological Surveillance (SINAVE) database. Individuals who had a positive RT-PCR SARS-CoV-2 test in August 2022 were contacted to participate in a telephonic interview approximately 9 and 12 months after the test. A hierarchical clustering analysis was performed, using Euclidean distance and Ward’s linkage. Clustering was performed in the 35 symptoms reported 9 and 12 months after the SARS-CoV-2 positive test and characterised considering age, sex, pre-existing health conditions and symptoms at time of SARS-CoV-2 infection. Results 552 individuals were included at 9 months and 458 at 12 months. The median age was 52 years (IQR: 40–64 years) and 59% were female. Hypertension and high cholesterol were the most frequently reported pre-existing health conditions. Memory loss, fatigue or weakness and joint pain were the most frequent symptoms reported 9 and 12 months after the positive test. Four clusters were identified at both times: no or minor symptoms; multi-symptoms; joint pain; and neurocognitive-related symptoms. Clusters remained similar in both times, but, within the neurocognitive cluster, memory loss and concentration issues increased in frequency at 12 months. Multi-symptoms cluster had older people, more females and more pre-existing health conditions at 9 months. However, at 12 months, older people and those with more pre-existing health conditions were in joint pain cluster. Conclusions Our results suggest that Long COVID is not the same for everyone. In our study, clusters remained similar at 9 and 12 months, except for a slight variation in the frequency of symptoms that composed each cluster. Understanding Long COVID clusters might help identify treatments for this condition. However, further validation of the observed clusters and analysis of its risk factors is needed.

The pandemic seems like a lifetime ago to many of us. However, the SARS-CoV-2 virus, which causes COVID-19, continues to circulate, mutate, and infect people. While most who contract the virus make a full recovery, for a growing number, a mysterious set of symptoms persists with varying severity. Long COVID is an umbrella term, rather than an illness, that describes this wide-ranging list of health issues. Intrigued? Click on to learn about the signs and symptoms of Long COVID.

The CDC estimates that just under 7% of adults in the United States continue to struggle with symptoms of long COVID.

What exactly does it mean when physicians say "long COVID," and what process do they go through when it comes to defining diseases? StudyFinds' Dr. Faith Coleman breaks it down.

Janet was so weak she couldn't cook her own food or even watch television

Demographic factors significantly influence long COVID symptom severity, according to study findings published in JRSM Open.

A recent study indicates that many individuals who were hospitalized with COVID-19 continue to experience cognitive and psychiatric issues two to three years after their infection.

Miller School and V.A. researchers will tease out the virus’s relationship with cardiac low-density lipoprotein (LDL) receptors.

Focuses on ten product approvals through 2027 Expects to submit next-generation COVID vaccine for approval in 2024 Expects to submit flu/COVID combination vaccine for approval in 2024 Announces positive Phase 3 results for its RSV vaccine for high-risk adults aged 18 to 59; expects to submit sBLA for U.S. approval in 2024 Announces positive Phase 3 results for its standalone flu vaccine for adults aged 65 and older relative to high-dose licensed comparator Announces norovirus vaccine advances into Phase 3 study, bringing the total of non-respiratory pivotal stage programs to five, across oncology, rare diseases and first-in-class vaccines Implements portfolio prioritization and cost efficiencies to reduce RD expense by $1.1 billion, from $4.8 billion in 2024E to $3.6-3.8 billion in 2027 Updates and extends financial framework through 2028 CAMBRIDGE, MA / ACCESSWIRE / September 12, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced program and financial updates demonstrating

The millions of people worldwide who are suffering from a vast array of disabling symptoms long after being infected with SARS-CoV-2 may eventually benefit from a new consensus definition of long C...